Target intelligence / Profile preview

Salmonella enterica serovar Enteritidis (S. Enteritidis)

Target
S. Enteritidis
Molecular classification
Other (Bacterial Pathogen): Salmonella enterica serovar Enteritidis is a Gram-negative bacterium; it is not a receptor, enzyme, transporter, or similar macromolecule
01

Overview

Salmonella enterica serovar Enteritidis is a Gram-negative, motile, facultatively anaerobic bacterium belonging to the family Enterobacteriaceae. It is one of the most common causes of foodborne illness globally, associated with outbreaks from contaminated poultry, eggs, and dairy products. The organism possesses multiple virulence factors, including the ability to form biofilms, survive harsh gastrointestinal conditions, and invade and persist in host tissues. It carries diverse antimicrobial resistance determinants—often located on plasmids—which contribute to its clinical significance by limiting effective treatment options. S. Enteritidis is characterized and subtyped through its flagellar H and somatic O antigens, and laboratory identification relies on serotyping, molecular detection of virulence genes, and antimicrobial susceptibility testing.

Other names
Salmonella EnteritidisS. EnteritidisSalmonella enterica subspecies enterica serovar Enteritidis
02

Mechanism of action

Antibiotic mechanisms targeting Salmonella Enteritidis primarily include: Inhibition of cell wall synthesis (e.g., beta-lactams like amoxicillin); Inhibition of protein synthesis (e.g., tetracyclines, aminoglycosides); Inhibition of DNA gyrase (e.g., quinolones); Inhibition of folate pathway (e.g., trimethoprim-sulfamethoxazole)

03

Biological functions

InfectionImmune response induction (via host-pathogen interactions)Biofilm formationAntibiotic resistance acquisition
04

Disease associations

Infection (foodborne illness, gastroenteritis, bacteremia)Food poisoning (worldwide public health concern)
05

Safety considerations

Multidrug resistance (MDR)Biofilm formation, complicating eradicationPotential for foodborne outbreaks and zoonotic transmissionHigh genetic diversity complicates outbreak tracing and controlResistance genes can be plasmid-borne and transferred to other bacteria
06

Interacting drugs

Amoxicillin

5 more in the full profile.

07

Biomarkers

Serovar-specific antigens (O and H antigens used for diagnostics)Detection of virulence genes (e.g., spvB, spiA, pagC, sipB, prgH, spaN, sitC, lpfC, iroN)Presence of antimicrobial resistance genes (e.g., blaTEM-1B, sul2, aph(6)-Id)

Beyond the preview

Go deeper on Salmonella enterica serovar Enteritidis (S. Enteritidis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Enteritidis (S. Enteritidis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call